🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 12 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/09/2019 | 54,73 | 55,68 | 53,71 | 53,81 | -1,68% | 3,59% | 409.246 |
| 06/09/2019 | 55,61 | 55,83 | 54,65 | 54,72 | -1,99% | 2,12% | 489.556 |
| 05/09/2019 | 55,63 | 56,97 | 55,06 | 55,83 | +1,64% | 3,44% | 588.301 |
| 04/09/2019 | 55,65 | 56,13 | 54,09 | 54,93 | +1,02% | 3,67% | 848.949 |
| 03/09/2019 | 56,14 | 56,33 | 53,57 | 54,38 | -4,11% | 4,92% | 680.634 |
| 30/08/2019 | 57,16 | 57,39 | 55,65 | 56,71 | -0,76% | 3,05% | 363.721 |
| 29/08/2019 | 57,28 | 57,95 | 56,41 | 57,15 | +1,01% | 2,69% | 325.409 |
| 28/08/2019 | 56,15 | 56,89 | 55,32 | 56,58 | +0,35% | 2,80% | 442.268 |
| 27/08/2019 | 58,25 | 58,79 | 56,15 | 56,38 | -2,65% | 4,53% | 512.319 |
| 26/08/2019 | 58,95 | 58,95 | 56,96 | 57,91 | +0,30% | 3,37% | 341.920 |
| 23/08/2019 | 59,66 | 60,93 | 57,36 | 57,74 | -3,49% | 5,98% | 465.030 |
| 22/08/2019 | 60,84 | 60,94 | 59,26 | 59,83 | -1,62% | 2,75% | 360.515 |
| 21/08/2019 | 60,21 | 61,00 | 59,44 | 60,81 | +1,85% | 2,59% | 727.121 |
| 20/08/2019 | 60,45 | 60,85 | 59,66 | 59,71 | -1,41% | 1,97% | 349.294 |
| 19/08/2019 | 60,05 | 61,04 | 59,05 | 60,56 | +2,25% | 3,31% | 918.519 |
| 16/08/2019 | 57,37 | 59,28 | 56,69 | 59,23 | +3,45% | 4,52% | 481.702 |
| 15/08/2019 | 58,58 | 58,76 | 56,93 | 57,25 | -1,96% | 3,13% | 407.964 |
| 14/08/2019 | 57,29 | 59,88 | 57,15 | 58,39 | -0,48% | 4,76% | 860.330 |
| 13/08/2019 | 56,19 | 58,85 | 56,19 | 58,67 | +3,45% | 4,72% | 631.101 |
| 12/08/2019 | 58,59 | 58,89 | 56,19 | 56,71 | -3,35% | 4,61% | 682.557 |
| 09/08/2019 | 58,05 | 59,11 | 57,09 | 58,68 | +0,19% | 3,48% | 717.503 |
| 08/08/2019 | 56,49 | 59,22 | 56,21 | 58,57 | +4,07% | 5,33% | 743.792 |
| 07/08/2019 | 56,38 | 57,39 | 55,33 | 56,28 | -1,58% | 3,65% | 685.763 |
| 06/08/2019 | 57,08 | 57,72 | 55,04 | 57,18 | +2,40% | 4,70% | 501.258 |
| 05/08/2019 | 58,40 | 58,43 | 55,36 | 55,84 | -5,84% | 5,24% | 1.122.421 |
| 02/08/2019 | 58,70 | 60,82 | 58,37 | 59,30 | -0,30% | 4,17% | 729.044 |
| 01/08/2019 | 58,24 | 61,24 | 58,22 | 59,48 | +4,20% | 5,18% | 1.157.206 |
| 31/07/2019 | 59,54 | 60,46 | 56,77 | 57,09 | -3,90% | 6,19% | 1.583.123 |
| 30/07/2019 | 66,23 | 66,54 | 58,67 | 59,40 | -11,38% | 11,90% | 2.299.824 |
| 29/07/2019 | 67,44 | 68,08 | 65,93 | 67,03 | -0,59% | 3,19% | 549.989 |